Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Napolitano

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Cancers|July 26, 2020
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal CancerCrescenzo D'Alterio, Antonella Zannetti, Anna Maria Trotta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Human melanoma metastases express functional CXCR4Stefania Scala, Paola Giuliano, Paolo A Ascierto, et al.
International Journal of Molecular Sciences|January 8, 2025
Oleanolic Acid Modulates DNA Damage Response to Camptothecin Increasing Cancer Cell DeathGiulio Mazzarotti, Maria Cuomo, Maria Carmen Ragosta, et al.
Antioxidants (Basel, Switzerland)|September 27, 2025
Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell LinesMargherita D'Angelo, Annamaria Medugno, Maria Cuomo, et al.
Frontiers in Immunology|August 8, 2022
Characterization of KRAS Mutational Regression in Oligometastatic PatientsAlessandro Ottaiano, Roberta Penta de Vera d'Aragona, Anna Maria Trotta, et al.
British Journal of Cancer|May 4, 2024
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patientsSara Santagata, Giuseppina Rea, Anna Maria Bello, et al.
Heliyon|August 22, 2024
CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterizationLuigi Portella, Giulia Bertolini, Giuseppe Guardascione, et al.
Cell Death & Disease|April 26, 2020
Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancerAlessandro Ottaiano, Luisa Circelli, Angela Lombardi, et al.
Journal for Immunotherapy of Cancer|March 5, 2022
In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapiesCaterina Ieranò, Dario Righelli, Crescenzo D'Alterio, et al.
Cell Death Discovery|March 28, 2026
CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cellsFederica Auletta, Caterina Ieranò, Dario Guido Di Febbraro, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Cancers|July 26, 2020
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal CancerCrescenzo D'Alterio, Antonella Zannetti, Anna Maria Trotta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Human melanoma metastases express functional CXCR4Stefania Scala, Paola Giuliano, Paolo A Ascierto, et al.
International Journal of Molecular Sciences|January 8, 2025
Oleanolic Acid Modulates DNA Damage Response to Camptothecin Increasing Cancer Cell DeathGiulio Mazzarotti, Maria Cuomo, Maria Carmen Ragosta, et al.
Antioxidants (Basel, Switzerland)|September 27, 2025
Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell LinesMargherita D'Angelo, Annamaria Medugno, Maria Cuomo, et al.
Frontiers in Immunology|August 8, 2022
Characterization of KRAS Mutational Regression in Oligometastatic PatientsAlessandro Ottaiano, Roberta Penta de Vera d'Aragona, Anna Maria Trotta, et al.
British Journal of Cancer|May 4, 2024
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patientsSara Santagata, Giuseppina Rea, Anna Maria Bello, et al.
Heliyon|August 22, 2024
CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterizationLuigi Portella, Giulia Bertolini, Giuseppe Guardascione, et al.
Cell Death & Disease|April 26, 2020
Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancerAlessandro Ottaiano, Luisa Circelli, Angela Lombardi, et al.
Journal for Immunotherapy of Cancer|March 5, 2022
In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapiesCaterina Ieranò, Dario Righelli, Crescenzo D'Alterio, et al.
Cell Death Discovery|March 28, 2026
CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cellsFederica Auletta, Caterina Ieranò, Dario Guido Di Febbraro, et al.
Pageof 12